Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Palatin's Case Strengthens as Rhythm's FDA Approval Validates Hypothalamic Obesity Market (PTN)
12 Health Care Stocks Moving In Friday's Pre-Market Session
Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN)
A. G. P. Maintains Palatin Technologies(PTN.US) With Buy Rating, Maintains Target Price $50
Earnings Call Summary | Palatin Technologies(PTN.US) Q2 2026 Earnings Conference
Palatin Technologies | 10-Q: Q2 2026 Earnings Report